113 related articles for article (PubMed ID: 9548513)
1. Suppression of collagen-induced arthritis by continuous administration of IL-4.
Horsfall AC; Butler DM; Marinova L; Warden PJ; Williams RO; Maini RN; Feldmann M
J Immunol; 1997 Dec; 159(11):5687-96. PubMed ID: 9548513
[TBL] [Abstract][Full Text] [Related]
2. Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.
Ross SE; Williams RO; Mason LJ; Mauri C; Marinova-Mutafchieva L; Malfait AM; Maini RN; Feldmann M
J Immunol; 1997 Dec; 159(12):6253-9. PubMed ID: 9550429
[TBL] [Abstract][Full Text] [Related]
3. Collagen-induced arthritis in DBA/1 mice: cytokine gene activation following immunization with type II collagen.
Stasiuk LM; Abehsira-Amar O; Fournier C
Cell Immunol; 1996 Nov; 173(2):269-75. PubMed ID: 8912886
[TBL] [Abstract][Full Text] [Related]
4. Treatment with an anti-IL-4 monoclonal antibody blocks suppression of collagen-induced arthritis in mice by oral administration of type II collagen.
Yoshino S
J Immunol; 1998 Mar; 160(6):3067-71. PubMed ID: 9510213
[TBL] [Abstract][Full Text] [Related]
5. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis.
Doncarli A; Stasiuk LM; Fournier C; Abehsira-Amar O
Eur J Immunol; 1997 Jun; 27(6):1451-8. PubMed ID: 9209498
[TBL] [Abstract][Full Text] [Related]
6. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen.
Garcia G; Komagata Y; Slavin AJ; Maron R; Weiner HL
J Autoimmun; 1999 Nov; 13(3):315-24. PubMed ID: 10550219
[TBL] [Abstract][Full Text] [Related]
7. Importance of dose of type II collagen in suppression of collagen-induced arthritis by nasal tolerance.
Derry CJ; Harper N; Davies DH; Murphy JJ; Staines NA
Arthritis Rheum; 2001 Aug; 44(8):1917-27. PubMed ID: 11508445
[TBL] [Abstract][Full Text] [Related]
8. Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines.
Finnegan A; Mikecz K; Tao P; Glant TT
J Immunol; 1999 Nov; 163(10):5383-90. PubMed ID: 10553063
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response.
Mauri C; Feldmann M; Williams RO
Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440
[TBL] [Abstract][Full Text] [Related]
10. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
[TBL] [Abstract][Full Text] [Related]
11. Induction of Th2 cytokines and control of collagen-induced arthritis by nondepleting anti-CD4 Abs.
Chu CQ; Londei M
J Immunol; 1996 Sep; 157(6):2685-9. PubMed ID: 8805674
[TBL] [Abstract][Full Text] [Related]
12. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis.
Härle P; Möbius D; Carr DJ; Schölmerich J; Straub RH
Arthritis Rheum; 2005 Apr; 52(4):1305-13. PubMed ID: 15818682
[TBL] [Abstract][Full Text] [Related]
13. Important role of interleukin-3 in the early phase of collagen-induced arthritis.
Brühl H; Cihak J; Niedermeier M; Denzel A; Rodriguez Gomez M; Talke Y; Goebel N; Plachý J; Stangassinger M; Mack M
Arthritis Rheum; 2009 May; 60(5):1352-61. PubMed ID: 19404955
[TBL] [Abstract][Full Text] [Related]
14. Dual role of IL-12 in early and late stages of murine collagen type II arthritis.
Joosten LA; Lubberts E; Helsen MM; van den Berg WB
J Immunol; 1997 Oct; 159(8):4094-102. PubMed ID: 9379000
[TBL] [Abstract][Full Text] [Related]
15. Schistosoma mansoni infection reduces severity of collagen-induced arthritis via down-regulation of pro-inflammatory mediators.
Osada Y; Shimizu S; Kumagai T; Yamada S; Kanazawa T
Int J Parasitol; 2009 Mar; 39(4):457-64. PubMed ID: 18835272
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis.
Nozaki Y; Yamagata T; Sugiyama M; Ikoma S; Kinoshita K; Funauchi M
Clin Immunol; 2006 Jun; 119(3):272-9. PubMed ID: 16412693
[TBL] [Abstract][Full Text] [Related]
17. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
[TBL] [Abstract][Full Text] [Related]
18. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer.
Ma Y; Thornton S; Duwel LE; Boivin GP; Giannini EH; Leiden JM; Bluestone JA; Hirsch R
J Immunol; 1998 Aug; 161(3):1516-24. PubMed ID: 9686619
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.
Lubberts E; Joosten LA; van Den Bersselaar L; Helsen MM; Bakker AC; van Meurs JB; Graham FL; Richards CD; van Den Berg WB
J Immunol; 1999 Oct; 163(8):4546-56. PubMed ID: 10510398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
